Sesti C, Simkhovich BZ, Kalvinsh I, Kloner RA«Mildronate, a novel fatty acid oxidation inhibitor and antianginal agent, reduces myocardial infarct size without affecting hemodynamics».J. Cardiovasc. Pharmacol.,47,3,3-2006,p.493–9. DOI: 10.1097/01.fjc.0000211732.76668.d2. PMID: 16633095.
Liepinsh E, Vilskersts R, Loca D, Kirjanova O, Pugovichs O, Kalvinsh I, Dambrova M«Mildronate, an inhibitor of carnitine biosynthesis, induces an increase in gamma-butyrobetaine contents and cardioprotection in isolated rat heart infarction».J. Cardiovasc. Pharmacol.,48,6,12-2006,p.314–9. DOI: 10.1097/01.fjc.0000250077.07702.23. PMID: 17204911.
Hayashi Y, Kirimoto T, Asaka N, Nakano M, Tajima K, Miyake H, Matsuura N«Beneficial effects of MET-88, a gamma-butyrobetaine hydroxylase inhibitor in rats with heart failure following myocardial infarction».Eur. J. Pharmacol.,395,3,5-2000,p.217–24. DOI: 10.1016/S0014-2999(00)00098-4. PMID: 10812052.
Leung IK, Krojer TJ, Kochan GT, Henry L, von Delft F, Claridge TD, Oppermann U, McDonough MA, Schofield CJ«Structural and mechanistic studies on γ-butyrobetaine hydroxylase».Chem. Biol.,17,12,12-2010,p.1316–24. DOI: 10.1016/j.chembiol.2010.09.016. PMID: 21168767.
Tars K, Rumnieks J, Zeltins A, Kazaks A, Kotelovica S, Leonciks A, Sharipo J, Viksna A, Kuka J, Liepinsh E, Dambrova M«Crystal structure of human gamma-butyrobetaine hydroxylase».Biochem. Biophys. Res. Commun.,398,4,8-2010,p.634–9. DOI: 10.1016/j.bbrc.2010.06.121. PMID: 20599753.
Sesti C, Simkhovich BZ, Kalvinsh I, Kloner RA«Mildronate, a novel fatty acid oxidation inhibitor and antianginal agent, reduces myocardial infarct size without affecting hemodynamics».J. Cardiovasc. Pharmacol.,47,3,3-2006,p.493–9. DOI: 10.1097/01.fjc.0000211732.76668.d2. PMID: 16633095.
Liepinsh E, Vilskersts R, Loca D, Kirjanova O, Pugovichs O, Kalvinsh I, Dambrova M«Mildronate, an inhibitor of carnitine biosynthesis, induces an increase in gamma-butyrobetaine contents and cardioprotection in isolated rat heart infarction».J. Cardiovasc. Pharmacol.,48,6,12-2006,p.314–9. DOI: 10.1097/01.fjc.0000250077.07702.23. PMID: 17204911.
Hayashi Y, Kirimoto T, Asaka N, Nakano M, Tajima K, Miyake H, Matsuura N«Beneficial effects of MET-88, a gamma-butyrobetaine hydroxylase inhibitor in rats with heart failure following myocardial infarction».Eur. J. Pharmacol.,395,3,5-2000,p.217–24. DOI: 10.1016/S0014-2999(00)00098-4. PMID: 10812052.
Leung IK, Krojer TJ, Kochan GT, Henry L, von Delft F, Claridge TD, Oppermann U, McDonough MA, Schofield CJ«Structural and mechanistic studies on γ-butyrobetaine hydroxylase».Chem. Biol.,17,12,12-2010,p.1316–24. DOI: 10.1016/j.chembiol.2010.09.016. PMID: 21168767.
Tars K, Rumnieks J, Zeltins A, Kazaks A, Kotelovica S, Leonciks A, Sharipo J, Viksna A, Kuka J, Liepinsh E, Dambrova M«Crystal structure of human gamma-butyrobetaine hydroxylase».Biochem. Biophys. Res. Commun.,398,4,8-2010,p.634–9. DOI: 10.1016/j.bbrc.2010.06.121. PMID: 20599753.